Originally published byEU-Startups
Resurrect Bio, a London-based agricultural BioTech startup developing disease-resistant crops, has closed its oversubscribed Series A funding round at €8.8 million ($10.3 million). In February 2026, the company made an initial close of over €6.8 million ($8 million) in its Series A round. The round was led by Corteva through its Corteva Catalyst platform, with […]
The post UK AgriBioTech startup Resurrect Bio closes €8.8 million Series A to develop disease-resistant crops appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Microsoft storms RAMPART, adds Clarity to agentic AI safety
12h ago
AI code accelerates production failures and spending, study finds
1d ago
Even Claude agrees: hole in its sandbox was real and dangerous
1d ago
Intel's CEO reveals early hiring challenges as bankruptcy concerns deterred top talent
1d ago
Earlybird raising €500m defence fund with French investor AVP, sources say
5h ago